Experimental studies on the toxicity of lithographic developer solution.
The purpose of this study was to determine whether the toxicity of a lithographic developer solution which contains hydroquinone is caused by hydroquinone or the alkaline lithographic developer solution. Male Wistar rats were divided into seven groups. In four groups, rats were dosed orally with 3% hydroquinone or 3% hydroquinone in 3% lithographic developer solution. Hydroquinone levels were measured after one and 24 hours. In two groups, rats were dosed orally with 6% hydroquinone or 6% hydroquinone in lithographic developer solution. In the seventh group, rats received the alkaline solution only. Hydroquinone measurement was made using gas chromatography-mass spectrometry. Hydroquinone was rapidly absorbed from the gastrointestinal tract and subsequently distributed throughout the body. Nearly all hydroquinone was excreted in the urine as either a glucuronide or a sulfate (78-82%) within 24 hours. All rats administered 6% hydroquinone in non-alkaline vehicle died, but the mortality rate of rats administered 6% hydroquinone in lithographic developer solution was 60%. Tissue hydroquinone was lower at one hour and 24 hours after administration in lithographic developer solution than in equal dose of hydroquinone in non-alkaline vehicle suggesting decreased absorption in an alkaline pH. Hydroquinone was not associated with gross pathologic changes of the intestine but all animals treated with lithographic developer solution or alkaline solution had congestion, hemorrhagic petechiae and purple-brown discoloration throughout the small intestine. The combination of alkaline/formaldehyde diluent with hydroquinone may delay hydroquinone absorption but increase the risk of intestinal necrosis.